The ninth China International Import Expo came to a close in Shanghai on Nov 10. Attending for the ninth consecutive year, Bayer once again showcased its Pharmaceuticals (with Radiology), Consumer Health, and Crop Science divisions, bringing nearly 30 debut exhibits in healthcare and modern agriculture.
Bayer also held and took part in 60 signing ceremonies, achievement releases, and exchange events centered on access to innovative medicines, clinical research, healthcare data and AI, primary care, evidence-based science, and market access, and signed more than 10 partnership agreements. On the heels of that success, Bayer has already signed up for next year's CIIE, moving from nine consecutive editions toward 10 years of "perfect attendance".
Zhou Xiaolan, executive vice-president of Bayer's Pharmaceuticals Division, Bayer AG, president of Bayer Pharmaceuticals China, and president of Bayer China, said: "After nine consecutive years at the CIIE, we are more convinced than ever of the unique value of this platform. It is not only a window into the latest innovations, but also an important bridge connecting global opportunities with China's development, bringing partners together and turning innovative ideas into real-world impact. Bayer has participated in the CIIE every year since its inception and has also benefited greatly from the opportunities it creates. Over the years, we have seen innovations move from exhibition showcases to the market, and initial agreements grow into long-term partnerships. We have also witnessed firsthand the growing strength and dynamism of China's innovation ecosystem. At this year's CIIE, guided by our mission 'Health for all, Hunger for none,' Bayer once again brought together our Pharmaceuticals, Consumer Health, and Crop Science businesses. From addressing major disease challenges and improving everyday health to advancing agricultural innovation and sustainability, one thing is increasingly clear to us: China is not only one of the world's largest and most dynamic markets, but is also emerging as an increasingly important source of innovation for the world. Looking ahead, we will continue to leverage the CIIE as a platform for openness and collaboration, bringing global innovation closer to the needs of the Chinese market while building stronger connections between China's innovation ecosystem and the rest of the world. Our ambition is to not only bring more global innovations to China faster, but also help more Chinese innovations reach the world."
